BEACON_VIEW_PHARMACY_LIMI - Accounts

BEACON VIEW PHARMACY LIMITED - Company Information

Print Friendly Version

Company Registration No. 03741632 (England and Wales)

BEACON VIEW PHARMACY LIMITED

UNAUDITED ABBREVIATED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 OCTOBER 2016

BEACON VIEW PHARMACY LIMITED

CONTENTS

Page

Abbreviated balance sheet

Notes to the abbreviated accounts

2 - 3

BEACON VIEW PHARMACY LIMITED

ABBREVIATED BALANCE SHEET

AS AT

31 OCTOBER 2016

- 1 -

2016

2015

Notes

Fixed assets

Tangible assets

1,068

1,340

Current assets

Stocks

46,044

42,530

Debtors

168,503

99,786

Cash at bank and in hand

1,202,239

1,166,204

1,416,786

1,308,520

Creditors: amounts falling due within one year

(1,097,734)

(882,464)

Net current assets

319,052

426,056

Total assets less current liabilities

320,120

427,396

Provisions for liabilities

(214)

(162)

319,906

427,234

Capital and reserves

Called up share capital

100

Profit and loss account

319,806

427,134

Shareholders' funds

319,906

427,234

For the financial year ended 31 October 2016 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.

These abbreviated financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime.

Approved by the Board for issue on 4 May 2017

R.G. Young

J.A. Young

Director

Company Registration No. 03741632

BEACON VIEW PHARMACY LIMITED

NOTES TO THE ABBREVIATED ACCOUNTS

FOR THE YEAR ENDED 31 OCTOBER 2016

- 2 -

Accounting policies

1.1

Accounting convention

The financial statements are prepared under the historical cost convention and in accordance with the Financial Reporting Standard for Smaller Entities (effective January 2015).

1.2

Compliance with accounting standards

The financial statements are prepared in accordance with applicable United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice), which have been applied consistently (except as otherwise stated).

1.3

Turnover

Turnover represents amounts receivable for goods and services net of VAT and trade discounts.

1.4

Tangible fixed assets and depreciation

Tangible fixed assets are stated at cost less depreciation. Depreciation is provided at rates calculated to write off the cost less estimated residual value of each asset over its expected useful life, as follows:

Fixtures, fittings & equipment

20% reducing balance

Motor vehicles

25% reducing balance

1.5

Pensions

The company operates a defined contribution scheme for the benefit of its employees. Contributions payable are charged to the profit and loss account in the year they are payable.

1.6

Deferred taxation

Deferred tax is provided in full in respect of taxation deferred by timing differences between the treatment of certain items for taxation and accounting purposes. The deferred tax balance has not been discounted.

Fixed assets

Tangible assets

Cost

At 1 November 2015 & at 31 October 2016

24,301

Depreciation

At 1 November 2015

22,961

Charge for the year

272

At 31 October 2016

23,233

Net book value

At 31 October 2016

1,068

At 31 October 2015

1,340

BEACON VIEW PHARMACY LIMITED

NOTES TO THE ABBREVIATED ACCOUNTS (CONTINUED)

FOR THE YEAR ENDED 31 OCTOBER 2016

- 3 -

Share capital

2016

2015

Allotted, called up and fully paid

100 ordinary shares of £1 each

100